Literature DB >> 11443747

Clinical relevance of Fas (APO-1/CD95) expression in laryngeal squamous cell carcinoma.

M C Jäckel1, C Mitteldorf, S Schweyer, L Füzesi.   

Abstract

BACKGROUND: Expression of Fas receptors renders tumor cells potentially susceptible to the host immune system. In squamous cell carcinomas of the head and neck, Fas has recently been found to be down-regulated in some cases; its prognostic value and correlation with clinicopathologic parameters, however, is yet to be delineated.
METHODS: Paraffin-embedded specimens of 88 primary laryngeal squamous cell carcinomas were investigated for Fas protein expression by immunohistochemistry. Apoptotic tumor cells were visualized using the nick end labeling method. To assess the immunologic reaction to the neoplasm, the intensity of lymphoplasmocytic stroma reaction was determined. The mean follow-up time amounted to 45.9 months (range, 1-144 months).
RESULTS: In tumor-adjacent normal mucosa and in most well-differentiated tumors, Fas expression was restricted to basal and parabasal cell layers. A diffuse pattern of staining reactions predominated in high-grade lesions (p <.001). The degree of Fas expression revealed a positive relationship with the intensity of lymphoplasmocytic stroma reaction (p =.002) but was unrelated to clinicopathologic parameters and to apoptotic rates of tumors. Neither Fas nor the lymphoplasmocytic stroma reaction had any impact on patient survival.
CONCLUSIONS: Up-regulation of cell surface Fas expression in laryngeal carcinoma seems to have a stimulatory effect on the immune cell infiltration of the stromal tissue. Its lack of clinical relevance might be due to an inhibition of intracellular Fas signal transduction, which represents a frequent strategy of tumor cells to escape Fas-mediated apoptosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11443747     DOI: 10.1002/hed.1091

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  5 in total

1.  A-kinase anchoring protein 2 is required for calcitonin-mediated invasion of cancer cells.

Authors:  Arvind Thakkar; Ahmed Aljameeli; Shibu Thomas; Girish V Shah
Journal:  Endocr Relat Cancer       Date:  2015-10-02       Impact factor: 5.678

2.  Tissue-specific alterations of PRL-1 and PRL-2 expression in cancer.

Authors:  Carmen M Dumaual; George E Sandusky; Han Weng Soo; Sean R Werner; Pamela L Crowell; Stephen K Randall
Journal:  Am J Transl Res       Date:  2012-01-05       Impact factor: 4.060

3.  Overexpression of cFLIP in head and neck squamous cell carcinoma and its clinicopathologic correlations.

Authors:  Xiuguo Li; Xinliang Pan; Hui Zhang; Dapeng Lei; Dayu Liu; Fenglei Xu; Xinyong Luan
Journal:  J Cancer Res Clin Oncol       Date:  2007-10-09       Impact factor: 4.553

4.  Relationship of 99mTc-HYNIC annexin V uptake to microvessel density, FasL and MMP-9 expression, and the number of tumour-infiltrating lymphocytes in head and neck carcinoma.

Authors:  Hubert Vermeersch; Kris Mervillie; Christophe Lahorte; David Loose; Rudi Andre Dierck; Neil Steinmetz; Claude Cuvelier; Guido Slegers; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-11       Impact factor: 9.236

5.  The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.

Authors:  Sangeeta K Bisheshar; Emma J De Ruiter; Lot A Devriese; Stefan M Willems
Journal:  Oncoimmunology       Date:  2020-04-23       Impact factor: 8.110

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.